Skip to main content
. Author manuscript; available in PMC: 2013 Jul 2.
Published in final edited form as: Nanomedicine (Lond). 2011 Apr 20;6(4):605–615. doi: 10.2217/nnm.11.21

Figure 3. Clot volume as a function of time when exposed to free and N-succinimidyl-S-acetylthioacetate-modified urokinase.

Figure 3

Sulfhydryl functionalization of urokinase at ratios of 3:1 and 6:1 SATA-modified sites per enzyme significantly decreased the overall enzymatic activity relative to free (0:1). *p < 0.05. NS: Nonsignificant; SATA: N-succinimidyl-S-acetylthioacetate urokinase.